533 related articles for article (PubMed ID: 23750020)
1. HAMI 3379, a CysLT2 receptor antagonist, attenuates ischemia-like neuronal injury by inhibiting microglial activation.
Zhang XY; Wang XR; Xu DM; Yu SY; Shi QJ; Zhang LH; Chen L; Fang SH; Lu YB; Zhang WP; Wei EQ
J Pharmacol Exp Ther; 2013 Aug; 346(2):328-41. PubMed ID: 23750020
[TBL] [Abstract][Full Text] [Related]
2. HAMI 3379, a CysLT2R antagonist, dose- and time-dependently attenuates brain injury and inhibits microglial inflammation after focal cerebral ischemia in rats.
Shi QJ; Wang H; Liu ZX; Fang SH; Song XM; Lu YB; Zhang WP; Sa XY; Ying HZ; Wei EQ
Neuroscience; 2015 Apr; 291():53-69. PubMed ID: 25681271
[TBL] [Abstract][Full Text] [Related]
3. [Antioxidative effects of cysteinyl leukotriene receptor antagonists montelukast and HAMI 3379 on ischemic injury in rat cortical neurons in vitro].
Xu DM; Zhang XY; Wang XR; Chen L; Zhang LH; Shi QJ; Fang SH; Lu YB; Zhang WP; Wei EQ
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2014 May; 43(3):257-64. PubMed ID: 24998647
[TBL] [Abstract][Full Text] [Related]
4. CysLT2 receptor mediates lipopolysaccharide-induced microglial inflammation and consequent neurotoxicity in vitro.
Chen L; Yang Y; Li CT; Zhang SR; Zheng W; Wei EQ; Zhang LH
Brain Res; 2015 Oct; 1624():433-445. PubMed ID: 26282348
[TBL] [Abstract][Full Text] [Related]
5. [Effects of cysteinyl leukotriene receptors on phagocytosis of mouse microglial cells].
Wang X; Lu Y; Zhang W; Wei E; Fang S
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2018 Jan; 47(1):10-18. PubMed ID: 30146806
[TBL] [Abstract][Full Text] [Related]
6. GPR17 mediates ischemia-like neuronal injury via microglial activation.
Zhao B; Wang H; Li CX; Song SW; Fang SH; Wei EQ; Shi QJ
Int J Mol Med; 2018 Nov; 42(5):2750-2762. PubMed ID: 30226562
[TBL] [Abstract][Full Text] [Related]
7. Cysteinyl Leukotriene Receptor 2 is Involved in Inflammation and Neuronal Damage by Mediating Microglia M1/M2 Polarization through NF-κB Pathway.
Zhao R; Ying M; Gu S; Yin W; Li Y; Yuan H; Fang S; Li M
Neuroscience; 2019 Dec; 422():99-118. PubMed ID: 31726033
[TBL] [Abstract][Full Text] [Related]
8. [Leukotriene D4 activates BV2 microglia in vitro].
Zhang Z; Luo J; Huang J; Liu Z; Fang S; Zhang WP; Wei E; Lu Y
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2013 May; 42(3):253-60. PubMed ID: 23801612
[TBL] [Abstract][Full Text] [Related]
9. Intracerebroventricular injection of HAMI 3379, a selective cysteinyl leukotriene receptor 2 antagonist, protects against acute brain injury after focal cerebral ischemia in rats.
Shi QJ; Xiao L; Zhao B; Zhang XY; Wang XR; Xu DM; Yu SY; Fang SH; Lu YB; Zhang WP; Sa XY; Wei EQ
Brain Res; 2012 Nov; 1484():57-67. PubMed ID: 23000196
[TBL] [Abstract][Full Text] [Related]
10. Agonist- and T(H)2 cytokine-induced up-regulation of cysteinyl leukotriene receptor messenger RNA in human monocytes.
Shirasaki H; Seki N; Fujita M; Kikuchi M; Kanaizumi E; Watanabe K; Himi T
Ann Allergy Asthma Immunol; 2007 Oct; 99(4):340-7. PubMed ID: 17941281
[TBL] [Abstract][Full Text] [Related]
11. Activation of CysLT receptors induces astrocyte proliferation and death after oxygen-glucose deprivation.
Huang XJ; Zhang WP; Li CT; Shi WZ; Fang SH; Lu YB; Chen Z; Wei EQ
Glia; 2008 Jan; 56(1):27-37. PubMed ID: 17910051
[TBL] [Abstract][Full Text] [Related]
12. Regulation of rotenone-induced microglial activation by 5-lipoxygenase and cysteinyl leukotriene receptor 1.
Zhang XY; Chen L; Yang Y; Xu DM; Zhang SR; Li CT; Zheng W; Yu SY; Wei EQ; Zhang LH
Brain Res; 2014 Jul; 1572():59-71. PubMed ID: 24858057
[TBL] [Abstract][Full Text] [Related]
13. Cysteinyl leukotriene receptor 1 mediates LTD4-induced activation of mouse microglial cells in vitro.
Yu SY; Zhang XY; Wang XR; Xu DM; Chen L; Zhang LH; Fang SH; Lu YB; Zhang WP; Wei EQ
Acta Pharmacol Sin; 2014 Jan; 35(1):33-40. PubMed ID: 24141567
[TBL] [Abstract][Full Text] [Related]
14. Cysteinyl leukotriene receptor 2 is spatiotemporally involved in neuron injury, astrocytosis and microgliosis after focal cerebral ischemia in rats.
Zhao CZ; Zhao B; Zhang XY; Huang XQ; Shi WZ; Liu HL; Fang SH; Lu YB; Zhang WP; Tang FD; Wei EQ
Neuroscience; 2011 Aug; 189():1-11. PubMed ID: 21664436
[TBL] [Abstract][Full Text] [Related]
15. Cysteinyl leukotriene receptor type 1 antagonist montelukast protects against injury of blood-brain barrier.
Zhou L; Sun X; Shi Y; Liu J; Luan G; Yang Y
Inflammopharmacology; 2019 Oct; 27(5):933-940. PubMed ID: 31313075
[TBL] [Abstract][Full Text] [Related]
16. Montelukast rescues primary neurons against Aβ1-42-induced toxicity through inhibiting CysLT1R-mediated NF-κB signaling.
Lai J; Mei ZL; Wang H; Hu M; Long Y; Miao MX; Li N; Hong H
Neurochem Int; 2014 Sep; 75():26-31. PubMed ID: 24879954
[TBL] [Abstract][Full Text] [Related]
17. A selective cysteinyl leukotriene receptor 2 antagonist blocks myocardial ischemia/reperfusion injury and vascular permeability in mice.
Ni NC; Yan D; Ballantyne LL; Barajas-Espinosa A; St Amand T; Pratt DA; Funk CD
J Pharmacol Exp Ther; 2011 Dec; 339(3):768-78. PubMed ID: 21903747
[TBL] [Abstract][Full Text] [Related]
18. Activation of 5-lipoxygenase after oxygen-glucose deprivation is partly mediated via NMDA receptor in rat cortical neurons.
Ge QF; Wei EQ; Zhang WP; Hu X; Huang XJ; Zhang L; Song Y; Ma ZQ; Chen Z; Luo JH
J Neurochem; 2006 May; 97(4):992-1004. PubMed ID: 16606359
[TBL] [Abstract][Full Text] [Related]
19. Montelukast attenuates neuropathic pain through inhibiting p38 mitogen-activated protein kinase and nuclear factor-kappa B in a rat model of chronic constriction injury.
Zhou C; Shi X; Huang H; Zhu Y; Wu Y
Anesth Analg; 2014 May; 118(5):1090-6. PubMed ID: 24686047
[TBL] [Abstract][Full Text] [Related]
20. Involvement of cysteinyl leukotriene receptors in angiogenesis in rat thoracic aortic rings.
Xu L; Zhang L; Liu L; Fang S; Lu Y; Wei E; Zhang W
Pharmazie; 2010 Oct; 65(10):750-4. PubMed ID: 21105577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
